Opioid Abuse and Corporate Innovation(with Kimberly Cornaggia, Kevin Pisciotta, and Zihan Ye)
August 10, 2022 draft at SSRNAbstract
We document spillover effects of the opioid epidemic on the migration and output of skilled
workers who drive corporate innovation. Exploiting geographic variation in opioid abuse unrelated
to economic conditions, we document outmigration of inventors and research labs from
affected areas. This dislocation is accompanied by declines in the quantity and value of patent
filings, new business formation, venture capital investment, and entrepreneurial activity. We
further document persistent long-term changes in local economic vibrancy. Because the displaced
workers are unlikely to abuse opioids, we interpret our results as spillover effects of
opioid abuse on non-users.